Tranexamic acid is highly efficacious for the treatment of melasma, with optimal outcomes seen through oral administration plus routine topical agents. The efficacy of tranexamic acid alone against ...

Within 4 weeks of starting treatment, patients experienced improvements in their condition, indicating an anti-inflammatory effect of the treatment. Study findings are supporting the use of 10% ...

Please provide your email address to receive an email when new articles are posted on . The patient, aged 66 years, had no previous edema. The patient tested positive for a mutation in the plasminogen ...

Please provide your email address to receive an email when new articles are posted on . Dermatologists should understand the chronicity of melasma. Topical tranexamic acid may be considered for ...

Researchers from Osaka University use machine learning to identify patients more likely to survive traumatic injury if treated with tranexamic acid. Worldwide, approximately 4.5 million people die of ...

Compared with placebo, tranexamic acid did not reduce hematoma growth in patients with intracerebral hemorrhage (ICH), a new study shows. In the randomized controlled trial, the rate of hematoma ...

Tinted sunscreens can help protect against the sun’s UV rays and should be worn if you are getting treated for melasma. Andy Newman AP Tranexamic acid has been used as a topical ingredient to help ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. Acne is nobody’s BFF. In fact, it’s the enemy we ...

Researchers have used machine learning to identify subgroups of trauma patients who are more likely to survive their injuries if treated with tranexamic acid. This treatment controls bleeding and ...

Prophylactic tranexamic acid showed no reduction in blood transfusion rates in open radical cystectomy patients. The trial found no significant differences in secondary outcomes, including estimated ...

Safety of tranexamic acid (TXA), even at higher doses, was upheld in a meta-analysis. Across 216 randomized trials in various medical disciplines, the incidence of thromboembolic events -- including ...